Trial NCT01685606

View at ClinicalTrials.gov 
Org. Study IDs: BrUOG 273

Last trial update was posted on 2022-03-04

MeSH Interventions

Immunomodulating Agents

MeSH Conditions

Burkitt Lymphoma Leukemia Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Myeloid Leukemia/Acute Lymphoblastic Leukemia Burkitts Lymphoma Diffuse Large Cell Lymphoma Mantle Cell Lymphoma T Cell Lymphomas

Stopping Reasons

Lack of accrual and low efficacy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID